In this study, 135 ROS1 fusions were identified in 134 NSCLC Chinese patients by DNA NGS and those fusions were classified as common and uncommon rearrangements based on the incidence (frequency limit = 5%). The gene discussed is ROS1; the disease is non-small cell lung carcinoma.